WallStreetZenWallStreetZen

NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Ownership - Who owns Sensei Biotherapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Sensei Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Der Horst Edward VanCHIEF SCIENTIFIC OFFICER2024-02-152,843$0.79
$2.25kSell
John CelebiPRESIDENT AND CEO2024-02-155,891$0.79
$4.65kSell
Erin ColganCHIEF FINANCIAL OFFICER2024-02-153,627$0.79
$2.87kSell
John CelebiPresident and CEO2023-09-11500$0.85
$425.00Buy
James PeyerDirector2023-07-311,587,302$1.26
$2.00MSell
Cambrian Biopharma Inc10% Owner2023-07-311,587,302$1.26
$2.00MSell
Apeiron Investment Group Ltd10% Owner2023-06-01955,738$1.58
$1.51MSell
Apeiron Investment Group Ltd10% Owner2023-06-012,485,923$1.58
$3.93MSell

1 of 1

SNSE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNSE insiders and whales buy or sell their stock.

SNSE Shareholders

What type of owners hold Sensei Biotherapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
James Peyer35.27%8,841,457$8.77MInsider
Hs Investments I LP17.65%4,425,998$4.39MInsider
Cambrian Biopharma Inc14.57%3,653,120$3.62MInsider
Newtyn Management LLC6.27%1,572,023$1.56MInstitution
Thomas G. Ricks2.73%685,632$680.15kInsider
Vanguard Group Inc2.29%573,651$569.06kInstitution
Renaissance Technologies LLC0.57%143,508$142.36kInstitution
Geode Capital Management LLC0.54%136,318$135.23kInstitution
Bridgeway Capital Management LLC0.45%112,900$112.00kInstitution
John Celebi0.42%105,420$104.58kInsider

1 of 3

SNSE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNSE11.82%71.99%Net SellingNet Selling
UBX25.70%51.52%Net SellingNet Selling
GDTC0.04%57.45%
PLUR0.58%99.42%
ONCT13.07%86.93%Net SellingNet Buying
View Top Biotech Stocks

Sensei Biotherapeutics Stock Ownership FAQ

Who owns Sensei Biotherapeutics?

Sensei Biotherapeutics (NASDAQ: SNSE) is owned by 11.82% institutional shareholders, 71.99% Sensei Biotherapeutics insiders, and 16.19% retail investors. James Peyer is the largest individual Sensei Biotherapeutics shareholder, owning 8.84M shares representing 35.27% of the company. James Peyer's Sensei Biotherapeutics shares are currently valued at $8.84M.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.